HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.

Abstract
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is a naturally occurring peptide of which the plasma concentration is increased 4- to 5-fold by angiotensin-converting enzyme inhibitors. We reported previously that, in models of both hypertension and postmyocardial infarction, Ac-SDKP reduces cardiac inflammation and fibrosis. However, it is unknown whether Ac-SDKP can prevent or reverse renal injury and dysfunction in hypertension. In the present study, we tested the hypothesis that, in rats with 5/6 nephrectomy (5/6Nx)-induced hypertension, Ac-SDKP reduces renal damage, albuminuria, and dysfunction by decreasing inflammatory cell infiltration and renal fibrosis and by increasing nephrin protein. Ac-SDKP (800 microg/kg per day, SC via osmotic minipump) or vehicle was either started 7 days before 5/6Nx (prevention) and continued for 3 weeks or started 3 weeks after 5/6Nx (reversal) and continued for another 3 weeks. Rats with 5/6Nx developed high blood pressure, left ventricular hypertrophy, albuminuria, decreased glomerular filtration rate, and increased macrophage infiltration (inflammation) and renal collagen content (fibrosis). Ac-SDKP did not affect blood pressure or left ventricular hypertrophy in either group; however, it significantly reduced albuminuria, renal inflammation, and fibrosis and improved glomerular filtration rate in both prevention and reversal groups. Moreover, slit diaphragm nephrin protein expression in the glomerular filtration barrier was significantly decreased in hypertensive rats. This effect was partially prevented or reversed by Ac-SDKP. We concluded that Ac-SDKP greatly attenuates albuminuria and renal fibrosis and improves renal function in rats with 5/6Nx. These effects may be related to decreased inflammation (macrophages) and increased nephrin protein.
AuthorsTang-Dong Liao, Xiao-Ping Yang, Martin D'Ambrosio, Yanlu Zhang, Nour-Eddine Rhaleb, Oscar A Carretero
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 55 Issue 2 Pg. 459-67 (Feb 2010) ISSN: 1524-4563 [Electronic] United States
PMID20026760 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Oligopeptides
  • acetyl-seryl-aspartyl-(N-acetyl)-lysyl-proline
Topics
  • Albuminuria (drug therapy, prevention & control)
  • Analysis of Variance
  • Animals
  • Biopsy, Needle
  • Blood Pressure (drug effects)
  • Body Weight
  • Disease Models, Animal
  • Glomerular Filtration Rate (drug effects)
  • Glomerulosclerosis, Focal Segmental (pathology, prevention & control)
  • Hypertension (drug therapy, pathology, physiopathology)
  • Immunohistochemistry
  • Kidney Function Tests
  • Kidney Glomerulus (drug effects, pathology)
  • Male
  • Nephrectomy
  • Oligopeptides (metabolism, pharmacology)
  • Organ Size
  • Probability
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reference Values
  • Sensitivity and Specificity
  • Urinalysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: